About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 578   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

Year : 2010  |  Volume : 17  |  Issue : 3  |  Page : 201-206 Table of Contents     

Fundus autofluorescence and optical coherence tomography findings in choroidal melanocytic lesions

1 Ophthalmic Oncology Section, Department of Ophthalmology, Yale University School of Medicine, New Haven, CT, USA
2 The Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA, USA

Date of Web Publication15-Jul-2010

Correspondence Address:
Miguel A Materin
Ocular Oncology Section, Ophthalmology Department, Yale University School of Medicine, 40 Temple Street, Suite 3A, New Haven, CT, 06443
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-9233.65489

Rights and Permissions

Purpose : To establish the characteristics of secondary retinal and retinal pigment epithelial (RPE) changes associated with the presence of choroidal melanoma and choroidal nevus as documented by optical coherence tomography (OCT) and fundus autofluorescence (FAF).
Materials and Methods : PubMed review of major English publications examining the correlation between clinical characteristics of choroidal melanoma and nevus with OCT and FAF findings.
Results : The intrinsic properties of choroidal melanoma, as well as overlying RPE changes, drusen, and lipofuscin are best characterized by FAF, while OCT is more sensitive for the identification of subretinal and intraretinal fluid as well as atrophy, degeneration, and photoreceptor loss in the neurosensory retina.
Conclusions : Secondary retinal changes associated with choroidal melanocytic lesions can be documented by OCT and FAF. OCT-evident changes are observed more often with choroidal melanoma than choroidal nevus. OCT is better suited to identify the overlying retinal detachment and edema, even before these findings are clinically apparent. FAF is most useful in documenting the presence of lipofuscin, a finding that represents one of the important criteria in differentiating small choroidal melanoma from benign choroidal nevus.

Keywords: Autofluorescence, Choroid, Eye, Melanoma, Nevus, Optical Coherence Tomography

How to cite this article:
Materin MA, Raducu R, Bianciotto C, Shields CL. Fundus autofluorescence and optical coherence tomography findings in choroidal melanocytic lesions. Middle East Afr J Ophthalmol 2010;17:201-6

How to cite this URL:
Materin MA, Raducu R, Bianciotto C, Shields CL. Fundus autofluorescence and optical coherence tomography findings in choroidal melanocytic lesions. Middle East Afr J Ophthalmol [serial online] 2010 [cited 2019 Sep 16];17:201-6. Available from: http://www.meajo.org/text.asp?2010/17/3/201/65489

   Introduction Top

The relative differentiation between small choroidal melanoma and large choroidal nevus can be challenging. In such cases, quantitative factors (largest basal diameter and height) and qualitative prognostic factors (drusen, retinal pigment epithelium (RPE) changes, orange pigment, and subretinal fluid) become important criteria in estimating the probability of growth. These qualitative prognostic factors represent secondary changes at the level of neurosensory retina and RPE, some of which can be induced by the presence of choroidal melanoma. Newer imaging devices such as optical coherence tomography (OCT) and fundus autofluorescence (FAF) may help characterize these changes and also detect them at subclinical level.

The criteria to predict the behavioral pattern of pigmented choroidal lesions have been developed by Shields and associates. [1],[2] Thickness of the lesion, presence of subretinal fluid, symptoms, orange pigment, distance from the margins to the optic disc of <3 mm, ultrasound hollowness, and absence of drusen are used for early detection of small melanomas. FAF and OCT are relatively new imaging technologies that may help with early diagnosis and treatment, with the possibility of affecting survival and decrease risk for metastasis and visual loss.

FAF is based on the intrinsic property of certain molecules to show transient emission of light, or fluorescence, when illuminated by an external light source. In the eye, many tissues have autofluorescence properties such as the cornea, lens, and the RPE.

Modified imaging systems have been developed to detect autofluorescence of the fundus in both normal and pathologic states. The main source of FAF is lipofuscin. Lipofuscin accumulates in the RPE from incomplete degradation and digestion of photoreceptor outer segments. Lipofuscin is a mixture of proteins, lipids, and small chromophores. Secondary to decreased or impaired lysosomal activity, the lipofuscin accumulates in the RPE. The intensity of FAF depends mainly on the amount and concentration of lipofuscin. Depending on the intensity of autofluorescence, a lesion may be isoautofluorescent, hypoautofluorescent, or hyperautofluorescent.

The intrinsic properties of melanoma, RPE changes and the presence of drusen and lipofuscin are better characterized by FAF, while the OCT is more sensitive for the identifying the subretinal and intraretinal fluid as well as changes in the neurosensory retina [Figure 1] and [Table 1].

   Autofluorescence Properties of Choroidal Melanocytic Lesions Top

Autofluorescence induced by choroidal melanoma

Shields et al.[3] have studied the intrinsic autofluorescence properties of choroidal melanoma. Using the standard technique of 580 nm excitation and 695 nm barrier filter on a digital fundus camera, they found that choroidal melanoma has mild autofluorescent properties. In their analysis of 51 eyes with melanoma, they found choroidal melanoma displayed hypoautofluorescence (39%), isoautofluorescence (6%), and hyperautofluorescence (55%). The autofluorescence was found to be increased in larger tumors, pigmented tumors and those with disrupted overlying RPE [Figure 2]. The autofluorescent property of melanoma was of a granular quality in 92% of cases and nongranular appearance in 8%. [3]

FAF of choroidal melanoma was studied by Lavinsky et al.[4] using scanning laser ophthalmoscopy with 488 nm excitation and 500 nm barrier filter, but there were no observable findings within the tumor.

Lohmann et al. studied the endogenous fluorescence of ocular malignant melanomas and found that lipofuscin granules were cleaved off and broken into small remnants in the melanoma. Several areas of increased fluorescence were seen throughout the RPE, as well as in underlying macrophages within the tumor. [5]

Farina et al. [6] evaluated patients with pigmented cutaneous lesions using selected wavelengths between 420 and 1040 nm. They found that the ideal wavelength was 940 nm for discriminating melanoma from nevus and 578 nm for outlining tumor margins. Near-infrared wavelengths (780-820 nm) penetrate deeper into the choroid than shorter wavelengths and can excite melanin-associated fluorophores. [7] This may play a future role in investigating the autofluorescence properties of choroidal melanocytic lesions.

RPE changes are better characterized with FAF than by OCT

OCT may show thickening, thinning, or irregularities at the level of RPE hyper-reflective layer.

RPE hyperplasia and metaplasia

Gunduz et al.[8] noticed in six (75%) of eight amelanotic choroidal melanocytic lesions, increased FAF intensities in areas of hyperpigmentation. They postulated that this might be due to accumulation of lipofuscin in areas of hyperpigmentation, as noted before in studies on age-related macular degeneration (AMD). [9],[10]

Lavinsky et al. [4] observed that areas of increased pigmentation and fibrous metaplasia showed increased AF in medium and large tumors. OCT may show RPE fibrous metaplasia appearing as a focal thickening of the RPE. [11]

RPE atrophy

FAF findings in patients with geographic atrophy secondary to AMD result in markedly reduced signal over atrophic areas, due to decreased RPE lipofuscin, which is the dominant fluorophore for FAF imaging. The adjacent zones surrounding atrophic patches show high-intensity FAF. Similarly, choroidal nevi may present hypoautofluorescence associated with chronic RPE degenerative features and RPE atrophy. [12] Choroidal melanoma usually displays more intrinsic overall autofluorescence when chronic RPE changes are noted. [3] It is similar to a window defect allowing more of the intrinsic autofluorescence to be detectable.


The presence of drusen counts as a negative correlation factor for growth in the case of choroidal melanocytic lesions. Drusen may have an increased, normal, or decreased FAF signal. [13] The variable autofluorescence characteristics are related to the nature of the RPE change overlying the drusen. Some drusen may present with normal or near normal autofluorescence, and some others may have decreased autofluorescence. Large soft foveal drusen have increased autofluorescence.

Delori et al. found that drusen may present as a central area of decreased autofluorescence surrounded by a ring of increased autofluorescence. [14] The authors of this study have postulated that the decreased central autofluorescence in drusen is determined by the RPE being stretched over the drusen, with a thinner layer of lipofuscin granules over the drusen.

Gunduz et al. found only partial correlation between increased FAF and drusen overlying choroidal melanocytic lesions. [15] Karadimas and Bouzas, [16] demonstrated that, in cases of drusenoid pigment epithelium detachment, FAF patterns vary from hyperautofluorescence to hypoautofluorescence. In these cases, the hyperautofluorescence may be caused by different fluorophores inside the fluid or drusenoid detachment, rather than by the lipofuscin. [16]


The lipofuscin overlying small choroidal melanomas is brightly hyperautofluorescent. Surrounding the bright lipofuscin hyperautofluorescence, there are adjacent dark hypoautofluorescent areas. This may possibly represent shifting and clumping of RPE cells with absence of RPE in between or possibly RPE atrophy. Detection of subclinical lipofuscin (orange pigment) by FAF imaging could play a role in the early detection of choroidal melanoma. [17] Lavinsky et al. [4] reported similar observations using the scanning laser ophthalmoscope (excitation, 488 nm; barrier filter, 500 nm).

Subretinal and intraretinal fluid

The presence of subretinal fluid represents a physical barrier between the outer segments of photoreceptors and the RPE, preventing normal phagocytosis of the shed outer segments of the photoreceptors. These subsequently accumulate on the outer retinal surface and in the subretinal space and represent a source of autofluorescence. [18],[19]

Histologically, the debris in the subretinal fluid consist of rounded or elongated densely packed multilamellar bodies that appear to result from the breakdown of outer segment disks. The retina anterior to the subretinal material shows attenuation of the photoreceptors layer. The subretinal material is bounded posteriorly by the RPE. [20]

Shields et al.[21] examined choroidal nevi, hemangiomas, and melanomas with overlying orange pigment and subretinal fluid and they found that the pigment corresponded to lipofuscin in macrophages in the subretinal space.

Takagi et al.[22] described similar findings for the retinal detachments associated with intraocular tumors. The subretinal precipitates were actually foam cells located around degenerated outer and inner segments of photoreceptor cells. These foam cells contained lysosomes with lipofuscin, and melanin.

In the analysis by Shields and colleagues on autofluorescence features of choroidal melanoma in 51 patients, 46 demonstrated active subretinal fluid, the fluid rim appeared with slightly more hyperautofluorescence than the fluid center. [3]

There are certain limiting factors for FAF imaging. First, media opacities, including lens opacification, decrease the FAF image contrast so that analysis of the image is not possible. Second, camera adjustment is crucial and motion artifacts should be excluded, since this may result in uneven background FAF and may lead to misinterpretation. Third, an absolute quantification of FAF images is not possible. This is probably because macular pigments vary with age, and a normative FAF imaging database is not available. The lack of reproducibility and consistency remains a major problem in many FAF studies. [23]

   Oct Findings of Choroidal Melanocytic Lesions Top

OCT findings associated with choroidal melanoma and nevi can be divided in three different patterns: serous retinal detachments around and overlying the tumor, intra-retinal cystic spaces in the overlying retina and loss of normal retinal architecture overlying the tumor [Figure 3].

Muscat et al.[24] studied the OCT findings associated with melanoma and nevi. Of 20 patients with the diagnosis of melanoma, all had serous retinal detachment on OCT, including eight cases in which no serous detachments had been noted on clinical examination. Eighteen patients also showed either intraretinal changes or distorted retinal architecture. In contrast, of 40 patients with choroidal nevi, 27 patients (67.5%) showed no retinal abnormalities on OCT. Twelve patients in this group had serous retinal detachments with only one of these noted clinically. [24]

Shields et al.[25] studied 120 eyes with choroidal nevus using OCT. They found intraretinal changes (15%), subretinal fluid (26%), retinal thinning (22%), drusen (41%), and RPE detachment (12%). Photoreceptor loss or attenuation was noted in 51% of cases. When comparing OCT with clinical examination, these authors concluded that OCT was more sensitive in the detection of related retinal edema, subretinal fluid, retinal thinning, photoreceptor attenuation, and RPE detachment.

Choroidal melanoma, in general, is poorly imaged on OCT. However, detection of overlying subretinal fluid by OCT could be important in confirming the suspicion of melanoma in eyes with borderline small or intermediate-sized tumors. The presence of subretinal fluid is a risk factor for growth of the tumor. Another OCT finding associated with neurosensory detachment in the case of the choroidal melanoma is the presence of small reflective bodies present on the outer surface of the detached retina. These bodies corresponded to aggregates of RPE cells that are seen clinically. [11]

Espinoza et al.[11] showed that OCT findings of subretinal fluid might have a predictive value in identifying choroidal melanocytic tumors that are likely to grow. In a study using OCT on 30 eyes with suspicious choroidal melanocytic lesions, tumor growth was found in only 8% of those with no subretinal fluid, 50% of those with active subretinal fluid, and 11% of those with retinal atrophy or edema. [11]

The findings on OCT of intraretinal cystic changes, RPE alterations, photoreceptor loss, and RPE detachment are related to chronic retinal degeneration and suggest a stable, chronic choroidal nevus. [25] Conversely, the presence of subretinal fluid and photoreceptor preservation suggests a more acute progression and more active lesion with risk for growth into melanoma. [11]

Specific OCT findings of choroidal nevus and melanoma are limited to the anterior surface of the lesion with minimal information deeper within the choroidal mass. Shields and associates noted increased thickness of the RPE-choriocapillaris layer (68%) for choroidal nevi. The anterior portion of the nevus can be hyporeflective (62%), isoreflective (29%), or hyper-reflective (9%). Hyporeflectivity was observed in 62% of pigmented nevi and 18% of nonpigmented nevi. [11] Because OCT is not helpful in evaluating internal tumor tissue characteristics, ultrasonography and OCT may be complementary techniques useful in evaluating a suspicious choroidal melanocytic tumor.

   References Top

1.Shields CL, Cater JC, Shields JA, Singh AD, Santos MC, Carvalho C. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol 2000;118:360-4.  Back to cited text no. 1      
2.Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH, et al. Choroidal nevus transformation into melanoma. Analysis of 2514 consecutive cases. Arch Ophthalmol 2009;127:981-7.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Shields CL, Bianciotto C, Pirondini C, Materin MA, Harmon SA, Shields JA. Autofluorescence of choroidal melanoma in 51 cases. Br J Ophthalmol 2008;92:617-22.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Lavinsky D, Belfort RN, Navajas E, Torres V, Martins MC, Belfort R Jr. Fundus autofluorescence of choroidal nevus and melanoma. Br J Ophthalmol 2007;91:1299-302.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Lohmann W, Wiegand W, Stolwijk TR, van Delft JL, van Best JA. Endogenous fluorescence of ocular malignant melanomas. Ophthalmologica 1995;209:7-10.  Back to cited text no. 5  [PUBMED]    
6.Farina B, Bartoli C, Bono A, Colombo A, Lualdi M, Tragni G, et al. Multispectral imaging approach in the diagnosis of cutaneous melanoma: Potentiality and limits. Phys Med Biol 2000;45:1243-54.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]  
7.Elsner AE, Burns SA, Weiter JJ, Delori FC. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res 1996;36:191-205.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]  
8.Gunduz K, Pulido JS, Bakri SJ, Petit-Fond E. Fundus autofluorescence in choroidal melanocytic lesions. Retina 2007;27:681-7.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]  
9.Solbach U, Keilhauer C, Knabben H, Wolf S. Imaging of retinal autofluorescence in patients with age-related macular degeneration. Retina 1997;17:385-9.   Back to cited text no. 9  [PUBMED]  [FULLTEXT]  
10.Bindewald A, Bird AC, Dandekar SS, Dolar-Szczasny J, Dreyhaupt J, Fitzke FW, et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci 2005;46:3309-14.  Back to cited text no. 10  [PUBMED]  [FULLTEXT]  
11.Espinoza G, Rosenblatt B, Harbour JW. Optical coherence tomography in the evaluation of retinal changes associated with suspicious choroidal melanocytic tumors. Am J Ophthalmol 2004;137:90-5.  Back to cited text no. 11  [PUBMED]  [FULLTEXT]  
12.Shields CL, Pirondini C, Bianciotto C, Materin MA, Harmon SA, Shields JA. Autofluorescence of choroidal nevus in 64 cases. Retina 2008;28:1035-43.  Back to cited text no. 12  [PUBMED]  [FULLTEXT]  
13.Lois N, Owens SL, Coco R, Hopkins J, Fitzke FW, Bird AC. Fundus autofluorescence in patients with age-related macular degeneration and high risk of visual loss. Am J Ophthalmol 2002;133:341-9.  Back to cited text no. 13  [PUBMED]  [FULLTEXT]  
14.Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci 2000;41:496-504.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]  
15.Gunduz K, Pulido JS, Bakri SJ, Luis A, Petit-Fond E, Link T. Fundus autofluorescence of choroidal melanocytic lesions and the effect of treatment. Trans Am Ophthalmol Soc 2007;105:172-9.  Back to cited text no. 15      
16.Karadimas P, Bouzas EA. Fundus autofluorescence imaging in serous and drusenoid pigment epithelial detachments associated with age-related macular degeneration. Am J Ophthalmol 2005;40:1163-5.  Back to cited text no. 16      
17.Shields CL, Bianciotto C, Pirondini C, Materin MA, Harmon SA, Shields JA. Autofluorescence of orange pigment overlying small choroidal melanoma. Retina 2007;27:1107-11.  Back to cited text no. 17  [PUBMED]  [FULLTEXT]  
18.Spaide RF, Klancnik JM Jr. Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology 2005;112:825-33.  Back to cited text no. 18  [PUBMED]  [FULLTEXT]  
19.Spaide RF, Noble K, Morgan A, Freund KB. Vitelliform macular dystrophy. Ophthalmology 2006;113:1392-400.  Back to cited text no. 19  [PUBMED]  [FULLTEXT]  
20.Spaide R. Autofluorescence from the outer retina and subretinal space: Hypothesis and review. Retina 2008;28:5-35.  Back to cited text no. 20  [PUBMED]  [FULLTEXT]  
21.Shields JA, Rodrigues MM, Sarin LK, Tasman WS, Annesley WH Jr. Lipofuscin pigment over benign and malignant choroidal tumors. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1976;81:871-81.  Back to cited text no. 21  [PUBMED]    
22.Takagi T, Tsuda N, Watanabe F, Noguchi S. Subretinal precipitates of retinal detachments associated with intraocular tumors. Ophthalmologica 1988;97:120-6.  Back to cited text no. 22      
23.Hopkins J, Walsh A, Chakravarthy U. Fundus autofluorescence in age-related macular degeneration: An epiphenomenon? Invest Ophthalmol Vis Sci 2006;47:2269-71.  Back to cited text no. 23  [PUBMED]  [FULLTEXT]  
24.Muscat S, Parks S, Kemp E, Keating D. Secondary retinal changes associated with choroidal naevi and melanomas documented by optical coherence tomography. Br J Ophthalmol 2004;88:120-4.  Back to cited text no. 24  [PUBMED]  [FULLTEXT]  
25.Shields CL, Mashayekhi A, Materin MA, Luo CK, Marr BP, Demirci H, et al. Optical coherence tomography of choroidal nevus in 120 patients. Retina 2005;25:243-52.  Back to cited text no. 25  [PUBMED]  [FULLTEXT]  


  [Figure 1], [Figure 2], [Figure 3]

  [Table 1]

This article has been cited by
1 Enhanced Depth Imaging Optical Coherence Tomography of Choroidal Nevus : Comparison to B-Scan Ultrasonography
Eui Yong Kweon
Journal of the Korean Ophthalmological Society. 2014; 55(3): 387
[Pubmed] | [DOI]
2 Long-term Echographic Surveillance of Elevated ChoroidalNevi
Daniele Doro,Olympia Kotsafti,Pierangela Cimatti
American Journal of Ophthalmology. 2013; 156(3): 438
[Pubmed] | [DOI]
3 Autofluorescence of intraocular tumours
Ana Almeida,Swathi Kaliki,Carol L. Shields
Current Opinion in Ophthalmology. 2013; 24(3): 222
[Pubmed] | [DOI]
4 Ocular tumors: Triumphs, challenges and controversies
Ralph C. Eagle
Saudi Journal of Ophthalmology. 2013; 27(3): 129
[Pubmed] | [DOI]
5 Enhanced Depth Imaging Optical Coherence Tomography of Choroidal Nevus in 104 Cases
Sanket U. Shah,Swathi Kaliki,Carol L. Shields,Sandor R. Ferenczy,Sarah A. Harmon,Jerry A. Shields
Ophthalmology. 2012; 119(5): 1066
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Oct Findings of ...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded203    
    Comments [Add]    
    Cited by others 5    

Recommend this journal